Clinical Trial Update: MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating MRG003 plus HX008 as first-line therapy for EGFR-positive locally advanced or metastatic penile cancer. The study is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Cancer
• Penile Squamous Cell Carcinoma

Drugs mentioned

• HX008
• MRG003

Snippet

Sponsor: Jiyan Liu | Conditions: Penile Cancer | Phase 1 | Status: RECRUITING